{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:56:49Z","timestamp":1787003809527,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2003,4,1]]},"DOI":"10.1038\/sj.bmt.1703891","type":"journal-article","created":{"date-parts":[[2003,4,11]],"date-time":"2003-04-11T12:31:03Z","timestamp":1050064263000},"page":"667-678","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":269,"title":["An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation"],"prefix":"10.1038","volume":"31","author":[{"given":"A J","family":"Peniket","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M C","family":"Ruiz de Elvira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Taghipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Cordonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Gluckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"de Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Santini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Blaise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Greinix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ferrant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Cornelissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A H","family":"Goldstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the European Bone Marrow Transplantation (EBMT) Lymphoma Registry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,4,11]]},"reference":[{"key":"BF1703891_CR1","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1182\/blood.V81.5.1137.1137","volume":"81","author":"R Chopra","year":"1993","unstructured":"Chopra R, McMillan AK, Linch DC et al. The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients. Blood 1993; 81: 1137\u20131145.","journal-title":"Blood"},{"key":"BF1703891_CR2","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/0140-6736(93)92411-L","volume":"341","author":"DC Linch","year":"1993","unstructured":"Linch DC, Winfield D, Goldstone AH et al. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial. Lancet 1993; 341: 1051\u20131054.","journal-title":"Lancet"},{"key":"BF1703891_CR3","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1200\/JCO.1995.13.3.588","volume":"13","author":"W Mills","year":"1993","unstructured":"Mills W, Chopra R, McMillan A et al. BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma. J Clin Oncol 1993; 13: 588\u2013595.","journal-title":"J Clin Oncol"},{"key":"BF1703891_CR4","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1056\/NEJM198706113162401","volume":"316","author":"T Philip","year":"1987","unstructured":"Philip T, Armitage JO, Spitzer G et al. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. N Engl J Med 1987; 316: 1493\u20131498.","journal-title":"N Engl J Med"},{"key":"BF1703891_CR5","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","volume":"333","author":"T Philip","year":"1995","unstructured":"Philip T, Guglielmi C, Hagenbeek A et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma [see comments]. N Engl J Med 1995; 333: 1540\u20131545.","journal-title":"N Engl J Med"},{"key":"BF1703891_CR6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1182\/blood.V91.1.331","volume":"91","author":"BM Leonard","year":"1998","unstructured":"Leonard BM, Hetu F, Busque L et al. Lymphoma cell burden in progenitor cell grafts measured by competitive polymerase chain reaction: less than one log difference between bone marrow and peripheral blood sources. Blood 1998; 91: 331\u2013339.","journal-title":"Blood"},{"key":"BF1703891_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3109\/10428199909083388","volume":"34","author":"LF Verdonck","year":"1999","unstructured":"Verdonck LF . Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma: updated results of the Utrecht experience. Leuk Lymphoma 1999; 34: 129\u2013136.","journal-title":"Leuk Lymphoma"},{"key":"BF1703891_CR8","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/S0140-6736(98)11135-2","volume":"353","author":"M Sykes","year":"1999","unstructured":"Sykes M, Preffer F, McAfee S et al. Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation. Lancet 1999; 353: 1755\u20131759.","journal-title":"Lancet"},{"key":"BF1703891_CR9","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1200\/JCO.1996.14.4.1291","volume":"14","author":"N Milpied","year":"1996","unstructured":"Milpied N, Fielding AK, Pearce RM et al. Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation. J Clin Oncol 1996; 14: 1291\u20131296.","journal-title":"J Clin Oncol"},{"key":"BF1703891_CR10","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1200\/JCO.1992.10.11.1690","volume":"10","author":"R Chopra","year":"1992","unstructured":"Chopra R, Goldstone AH, Pearce R et al. Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data. J Clin Oncol 1992; 10: 1690\u20131695.","journal-title":"J Clin Oncol"},{"key":"BF1703891_CR11","doi-asserted-by":"crossref","unstructured":"National Cancer Institute. Sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of Working Formulation for clinical usage. Cancer 1982; 29: 2112\u20132129.","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2"},{"key":"BF1703891_CR12","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H et al. A revised European\u2013American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361\u20131392.","journal-title":"Blood"},{"key":"BF1703891_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/sj.bmt.1700614","volume":"19","author":"M de Lima","year":"1997","unstructured":"de Lima M, van Besien K, Giralt SA et al. Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma. Bone Marrow Transplant 1997; 19: 121\u2013127.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703891_CR14","first-page":"665","volume":"18","author":"P Moreau","year":"1996","unstructured":"Moreau P, Mechinaud F, Mahe B et al. Successful allogeneic bone marrow transplantation for early relapse after autologous bone marrow transplantation in two cases of aggressive high-grade non-Hodgkin's lymphoma. Bone Marrow Transplant 1996; 18: 665\u2013667.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703891_CR15","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/sj.bmt.1700989","volume":"20","author":"T Tsai","year":"1997","unstructured":"Tsai T, Goodman S, Saez R et al. Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation. Bone Marrow Transplant 1997; 20: 859\u2013863.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703891_CR16","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/blood.V77.3.649.649","volume":"7","author":"RJ Jones","year":"1991","unstructured":"Jones RJ, Ambinder RF, Piantadosi S et al. Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. Blood 1991; 7: 649\u2013653.","journal-title":"Blood"},{"key":"BF1703891_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/sj.bmt.1700904","volume":"20","author":"EJ Dann","year":"1997","unstructured":"Dann EJ, Daugherty CK, Larson RA . Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma. Bone Marrow Transplant 1997; 20: 369\u2013374.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703891_CR18","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood.V84.4.1050.1050","volume":"84","author":"V Ratanatharathorn","year":"1994","unstructured":"Ratanatharathorn V, Uberti J, Karanes C et al. Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma. Blood 1994; 84: 1050\u20131055.","journal-title":"Blood"},{"key":"BF1703891_CR19","first-page":"47","volume":"5","author":"EA Copelan","year":"1990","unstructured":"Copelan EA, Kapoor N, Gibbins B et al. Allogeneic marrow transplantation in non-Hodgkin's lymphoma. Bone Marrow Transplant 1990; 5: 47\u201350.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703891_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s002770050240","volume":"73","author":"IC Schouten","year":"1996","unstructured":"Schouten IC, Raemaekers JJ, Kluin NH et al. High-dose therapy followed by bone marrow transplantation for relapsed follicular non-Hodgkin's lymphoma. Dutch HOVON Group. Ann Hematol 1996; 73: 273\u2013277.","journal-title":"Ann Hematol"},{"key":"BF1703891_CR21","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1200\/JCO.1995.13.5.1096","volume":"13","author":"KW van Besien","year":"1995","unstructured":"van Besien KW, Khouri IF, Giralt SA et al. Allogeneic bone marrow transplantation for refractory and recurrent lowgrade lymphoma: the case for aggressive management. J Clin Oncol 1995; 13: 1096\u20131102.","journal-title":"J Clin Oncol"},{"key":"BF1703891_CR22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0002-9343(97)89488-0","volume":"100","author":"KW van Besien","year":"1996","unstructured":"van Besien KW, Mehra RC, Giralt SA et al. Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology. Am J Med 1996; 100: 299\u2013307.","journal-title":"Am J Med"},{"key":"BF1703891_CR23","first-page":"1832","volume":"92","author":"KW van Besien","year":"1998","unstructured":"van Besien KW, Sobocinski KA, Rowlings PA et al. Allogeneic bone marrow transplantation for low-grade lymphoma. Blood 1998; 92: 1832\u20131836.","journal-title":"Blood"},{"key":"BF1703891_CR24","first-page":"1120a","volume":"20","author":"M Attal","year":"1997","unstructured":"Attal M, Socie G, Molina L et al. Allogeneic bone marrow transplantation for refractory and recurrent follicular lymphoma: a case-matched analysis with autologous transplantation from the French bone marrow transplant group registry data. Blood 1997; 20: 1120a.","journal-title":"Blood"},{"key":"BF1703891_CR25","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1046\/j.1365-2141.1998.00539.x","volume":"100","author":"CM Mandigers","year":"1998","unstructured":"Mandigers CM, Raemaekers JM, Schattenberg AV et al. Allogeneic bone marrow transplantation with T-cell-depleted marrow grafts for patients with poor-risk relapsed low-grade non-Hodgkin's lymphoma. Br J Haematol 1998; 100: 198\u2013206.","journal-title":"Br J Haematol"},{"key":"BF1703891_CR26","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1182\/blood.V73.6.1720.1720","volume":"73","author":"KM Sullivan","year":"1989","unstructured":"Sullivan KM, Weiden PL, Storb R et al. Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 1989; 73: 1720\u20131728.","journal-title":"Blood"},{"key":"BF1703891_CR27","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/sj.bmt.1700781","volume":"19","author":"KW van Besien","year":"1997","unstructured":"van Besien KW, de Lima M, Giralt SA et al. Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect. Bone Marrow Transplant 1997; 19: 977\u2013982.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703891_CR28","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1200\/JCO.1998.16.8.2817","volume":"16","author":"IF Khouri","year":"1998","unstructured":"Khouri IF, Keating M, Champlin R et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol 1998; 16: 2817\u20132824.","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"BF1703891_CR29","first-page":"348a","volume":"94","author":"PD Kottaridis","year":"1999","unstructured":"Kottaridis PD, Chakraverty R, Milligan D et al. A non-myeloablative regimen for allografting high-risk patients: low toxicity, stable engraftment without GVHD, disease control and potential for GVL with adoptive immunotherapy. Blood. 1999; 94 (Suppl 1): 348a.","journal-title":"Blood"},{"issue":"Suppl 1","key":"BF1703891_CR30","first-page":"348a","volume":"94","author":"I Khouri","year":"1999","unstructured":"Khouri I, Lee M-S, Palmer L et al. Transplant-lite using fludarabine-cyclophosphamide (FC) and allogeneic stem cell transplant (AlloSCT) for low-grade lymphoma (LGL). Blood. 1999; 94 (Suppl 1): 348a.","journal-title":"Blood"},{"issue":"Suppl. 1","key":"BF1703891_CR31","first-page":"348a","volume":"94","author":"NH Russell","year":"1999","unstructured":"Russell NH, Cull G, Byrne JL et al. Evaluation of non-myeloablative conditioning combining BEAM within vivo pre-transplant Campath-IG for allogeneic transplantation in patients with lymphoma. Blood 1999; 94 (Suppl. 1): 348a.","journal-title":"Blood"},{"key":"BF1703891_CR32","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1182\/blood.V85.6.1659.bloodjournal8561659","volume":"85","author":"M Korbling","year":"1995","unstructured":"Korbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995; 85: 1659\u20131665.","journal-title":"Blood"},{"issue":"Suppl. 1","key":"BF1703891_CR33","first-page":"368a","volume":"94","author":"W Bensinger","year":"1999","unstructured":"Bensinger W, Martin P, Clift R et al. A prospective randomised trial of peripheral blood stem cells or marrow for patients undergoing allogeneic transplantation for hematologic malignancies. Blood 1999; 94 (Suppl. 1): 368a.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1703891","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703891.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703891.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T19:38:47Z","timestamp":1648064327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1703891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4,1]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2003,4,1]]}},"alternative-id":["BF1703891"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1703891","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4,1]]},"assertion":[{"value":"3 January 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}